Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Derivatives in Neuropathic Pain
NCT05351801Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2023
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in neuropathic pain, sponsored by VA Office of Research & Development. Started Jun 2023; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05351801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351801.